Cloudbreak Pharma completes FDA end-of-phase-2 meeting for CBT-004 in pinguecula ...
U.S. News & World Report has released its annual list of Best Hospitals, and Bascom Palmer Eye Institute achieved the top ...
In this Q&A, Vance Thompson, MD, clears up myths about dry eye and LASIK wearing off, and explains how better screening and ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Roche’s ...
The FDA has cleared an IND for RAG-1C, a first-in-class saRNA therapy targeting proliferative vitreoretinopathy.
The approval establishes LYTENAVA as the first and only FDA-approved ophthalmic formulation of bevacizumab for the treatment ...
Three cases illustrate treatment switches and extension intervals across retinal vein occlusion, age-related macular degeneration, and diabetic retinopathy.
Retina specialists Baruch D. Kuppermann, MD, PhD, and Firas M. Rahhal, MD, discuss the significance of bevacizumab-vikg's ...
The most meaningful part is not technological. It is personal. Vision-threatening diseases create uncertainty and fear. Home ...
Gulani, MD, introduces the Gulani classification of refractive lens exchange, a 4-type framework for individualizing premium ...
Louie Cai, MD: Manual prescreening for clinical trials is very labor intensive, taking as long as 30 minutes to an hour per ...
Real-world Spectrum data show aflibercept 8 mg boosts early vision and retinal anatomy in wet AMD, including switch patients. Welcome back to another Ophthalmology Times Europe Rapid Readout. In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results